The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study
We evaluated the efficacy of fremanezumab, a fully humanized monoclonal antibody that selectively targets calcitonin gene-related peptide, in patients with chronic migraine (CM) with and without medication ove...
21:114The Journal of Headache and Pain 2020
No hay comentarios:
Publicar un comentario